arXiv · 2207.03222
COVID-19 adaptive humoral immunity models: weakly neutralizing versus antibody-disease enhancement scenarios
Abstract
The interplay between the virus, infected cells and the immune responses to SARS-CoV-2 is still under debate. Extending the basic model of viral dynamics we propose here a formal approach to describe the neutralizing versus weakly (or non-)neutralizing scenarios and compare with the possible effects of antibody-dependent enhancement (ADE). The theoretical model is consistent with data available from the literature; we show that weakly neutralizing antibodies or ADE can both give rise to either final virus clearance or disease progression, but the immuno-dynamic is different in each case. Given that a significant part of the world population is already naturally immunized or vaccinated, we also discuss the implications on secondary infections infections following vaccination or in presence of immune system dysfunctions.
Explore related subjects
Keep this discovery
Antoine Danchin, Oriane Pagani-Azizi, Gabriel Turinici, Ghozlane Yahiaoui. 2022-07-07. COVID-19 adaptive humoral immunity models: weakly neutralizing versus antibody-disease enhancement scenarios. https://arxiv.org/abs/2207.03222
Cite the original work for its findings. Save a collection to share your selection of sources.